NASDAQ:ZIMV - Nasdaq - US98888T1079 - Common Stock - Currency: USD
NASDAQ:ZIMV (5/19/2025, 3:22:59 PM)
8.75
-0.26 (-2.89%)
The current stock price of ZIMV is 8.75 USD. In the past month the price decreased by -4.05%. In the past year, price decreased by -47.06%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.26 | 234.27B | ||
ISRG | INTUITIVE SURGICAL INC | 73.34 | 200.84B | ||
BSX | BOSTON SCIENTIFIC CORP | 39.4 | 157.34B | ||
SYK | STRYKER CORP | 31.4 | 150.19B | ||
MDT | MEDTRONIC PLC | 16.25 | 111.32B | ||
BDX | BECTON DICKINSON AND CO | 12.51 | 50.62B | ||
EW | EDWARDS LIFESCIENCES CORP | 29.95 | 45.77B | ||
IDXX | IDEXX LABORATORIES INC | 45.54 | 42.08B | ||
RMD | RESMED INC | 27.77 | 36.97B | ||
DXCM | DEXCOM INC | 52.57 | 34.01B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 15.85 | 33.39B | ||
STE | STERIS PLC | 26.95 | 24.73B |
Zimvie, Inc. operates as a holding company, which engages in the manufacture, design, and distribution of medical devices and surgical instruments. The company is headquartered in Westminster, Colorado and currently employs 1,770 full-time employees. The company went IPO on 2022-02-14. The company develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. The company works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems, dental biomaterial products and digital dentistry solutions. The key products in its dental implant systems portfolio consist of TSX Implant System, Tapered Screw-Vent (TSV) Implant System, T3 Pro Implant System, T3 Implant System, OSSEOTITE Implant System, Trabecular Metal Implant System, BellaTek Patient Specific Products, GenTek Restorative Portfolio, and Encode Healing Abutment / Impression System. The company markets its products in about 50 countries.
ZIMVIE INC
10225 Westmoor Drive
Westminster COLORADO US
Employees: 1770
Phone: 13034437500
The current stock price of ZIMV is 8.75 USD. The price decreased by -2.89% in the last trading session.
The exchange symbol of ZIMVIE INC is ZIMV and it is listed on the Nasdaq exchange.
ZIMV stock is listed on the Nasdaq exchange.
9 analysts have analysed ZIMV and the average price target is 17.63 USD. This implies a price increase of 101.44% is expected in the next year compared to the current price of 8.75. Check the ZIMVIE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ZIMVIE INC (ZIMV) has a market capitalization of 243.69M USD. This makes ZIMV a Micro Cap stock.
ZIMVIE INC (ZIMV) currently has 1770 employees.
ZIMVIE INC (ZIMV) has a support level at 8.88 and a resistance level at 9.45. Check the full technical report for a detailed analysis of ZIMV support and resistance levels.
The Revenue of ZIMVIE INC (ZIMV) is expected to decline by -0.32% in the next year. Check the estimates tab for more information on the ZIMV EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ZIMV does not pay a dividend.
ZIMVIE INC (ZIMV) will report earnings on 2025-07-31, after the market close.
The PE ratio for ZIMVIE INC (ZIMV) is 11.22. This is based on the reported non-GAAP earnings per share of 0.78 and the current share price of 8.75 USD. Check the full fundamental report for a full analysis of the valuation metrics for ZIMV.
The outstanding short interest for ZIMVIE INC (ZIMV) is 1.79% of its float. Check the ownership tab for more information on the ZIMV short interest.
ChartMill assigns a fundamental rating of 4 / 10 to ZIMV. While ZIMV is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months ZIMV reported a non-GAAP Earnings per Share(EPS) of 0.78. The EPS increased by 81.4% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -2.62% | ||
ROE | -4.94% | ||
Debt/Equity | 0.56 |
ChartMill assigns a Buy % Consensus number of 49% to ZIMV. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 44.36% and a revenue growth -0.32% for ZIMV